Safety and Performance Study of the Edwards SAPIEN 3 Transcatheter Heart Valve/ The SAPIEN 3 Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 250 participants.
Also called NCT01808287
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 250 participants
- Sponsor
- Registry
-
NCT01808287
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada, France, Germany, Italy, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01808287. Non-randomized; no masking; primary purpose treatment. Start 2013-01 (actual); primary completion 2013-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Performance Study of the Edwards SAPIEN 3 Transcatheter Heart Valve/ The SAPIEN 3 Study
- Acronym
- SAPIEN3
- Condition
- Aortic Valve Disease
- Intervention (Device)
- Edwards SAPIEN 3 Transcatheter Heart Valve
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct01808287- Content hash
ff3a12157a42e6a4fefe4017c6099cd36193593c8ead210c9b298612727ced0a